Balance Sheets - USD ($)	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash	$ 1,266,131	$ 1,231
Deferred offering costs		303,281
Prepaid expenses	57,874	713
Due from related parties		130,000
Total current assets	1,324,005	435,225
Deferred financing costs		4,338,543
Total assets	1,324,005	4,773,768
Current liabilities:
Trade accounts payable and accrued liabilities	587,536	707,187
Due to related parties	93,432	527,377
Related party line of credit		101,000
Total current liabilities	680,968	1,335,564
Total liabilities	680,968	1,335,564
Stockholders’ Equity
Preferred Stock, no par value, 100,000,000 shares authorized and none issued or outstanding.
Common Stock, no par value; 300,000,000 shares authorized, 29,762,671 and 28,609,814 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively.
Additional paid-in capital	31,239,895	17,502,346
Accumulated deficit	(30,596,858)	(14,064,142)
Total stockholders’ equity	643,037	3,438,204
Total liabilities and stockholders’ equity	$ 1,324,005	$ 4,773,768

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.